TWO SIGMA INVESTMENTS, LP - CELLULAR BIOMEDICINE GROUP I ownership

Back to all holdings Add to watchlist

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 45 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q3 2020$440,000
+85.7%
23,999
+51.4%
0.00%
+100.0%
Q2 2020$237,000
-30.5%
15,851
-24.4%
0.00%0.0%
Q4 2019$341,000–20,974–0.00%–
 Download
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q4 2019.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders